Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Oruka Therapeutics CEO Lawrence Klein disposes of $2.09 million in common shares

Oruka Therapeutics CEO Lawrence Klein disposes of $2.09 million in common shares

BitgetBitget2026/10/02 23:55
  • Oruka Therapeutics CEO Lawrence Otto Klein exercised an employee warrant for 25,000 shares at $7.80 on Oct. 1, 2026.
  • He sold 25,000 shares on Oct. 1, 2026 at weighted-average prices of $83.3979, $84.0256, $84.78.
  • Directly held common stock fell to 923,128 shares following the transactions.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oruka Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000907654-26-000104), on October 02, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Barclays, Deutsche Bank, and others: AI boom supports the US dollar, rally expected to continue until 2027

Barclays and Deutsche Bank believe that the artificial intelligence boom will continue to support a strong US dollar.

智通财经•2026/11/18 23:32
Barclays, Deutsche Bank, and others: AI boom supports the US dollar, rally expected to continue until 2027

US Pending Home Sales in October Drop to Historic Lows as High Interest Rates Continue to Suppress Housing Demand

The U.S. Pending Home Sales Index for October fell to 63, plunging 17% year-on-year and 4.7% month-on-month, reaching the lowest level on record since 2001. As a result, sales of existing homes based on contract closings have dropped to the lowest level since 2010. The chief economist of NAR stated, "Mortgage rates seem to have peaked, and October may represent the low point for contract signings in the current real estate cycle."

华尔街见闻•2026/11/18 22:48
US Pending Home Sales in October Drop to Historic Lows as High Interest Rates Continue to Suppress Housing Demand